Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$737,352
-$10,387,654 QoQ
Shares Held
9,900
-96.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#244
of 462 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWINBEECH CAPITAL LP holds $19,348,066 across 17 Biotechnology names. BBIO ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
18,135 | $4,438,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,325 | $4,312,254 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
42,192 | $2,452,620 | |
| 4 | INSM |
INSMED Inc
|
13,646 | $1,454,936 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
31,387 | $1,214,676 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
9,900 | $737,352 | |
| 7 | VERA |
Vera Therapeutics, Inc.
|
16,200 | $695,142 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
28,337 | $682,354 |
All Filings in BBIO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $737,352 | 9,900 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $11,125,006 | 321,811 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $1,980,737 | 77,798 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,643,786 | 341,247 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $2,832,375 | 107,409 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $2,014,156 | 264,325 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $907,358 | 54,398 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $419,767 | 8,956 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||